Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026)
Hims & Hers Health (HIMS) posted Change in Acquisitions & Divestments of $93.3 million for Q1 2026, down 14.21% sequentially from $108.7 million in Q4 2025, and up 197.53% YoY from $31.3 million in Q1 2025.
Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $93.3 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 197.53% year-over-year to $93.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170.6 million (up 19.66% YoY) and the FY2025 annual result came in at $108.7 million, down 47.98% from the prior year.
- Change in Acquisitions & Divestments eased to $93.3 million in Q1 2026 per HIMS's latest filing, from $108.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $208.2 million in Q4 2024 and troughed at -$125.4 million in Q3 2024.
- A 5-year average of $40.4 million and a median of $31.3 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2024 and 2026: Change in Acquisitions & Divestments sank 14061.02% in 2024, then soared 197.53% in 2026.
- Over 5 years, Change in Acquisitions & Divestments stood at $59.5 million in 2022, then slumped by 98.49% to $898000.0 in 2023, then jumped by 23086.53% to $208.2 million in 2024, then slumped by 47.8% to $108.7 million in 2025, then fell by 14.21% to $93.3 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $93.3 million, $108.7 million, and -$60.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 257.51 Mn |
| Jun 30, 2026 | 257.51 Mn |
| Mar 31, 2026 | 93.25 Mn |
| Mar 31, 2026 | 93.25 Mn |
| Dec 31, 2025 | 108.70 Mn |
| Dec 31, 2025 | 108.70 Mn |
| Sep 30, 2025 | -60.57 Mn |
| Sep 30, 2025 | -60.57 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Mar 31, 2025 | 31.34 Mn |
| Mar 31, 2025 | 31.34 Mn |
| Dec 31, 2024 | 208.22 Mn |
| Dec 31, 2024 | 208.22 Mn |
| Sep 30, 2024 | -125.37 Mn |
| Sep 30, 2024 | -125.37 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 97.70 Mn |
| Mar 31, 2024 | 97.70 Mn |